Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Club 100 Plus is a private investors' club and angel investment group based in Giv'atayim, Israel. It enables members to build diversified portfolios across startup companies, U.S. real estate, infrastructure, and alternative funds rather than operating as a drug developer, biotech company, or healthcare services provider. Public descriptions indicate the club has nearly 1,000 members and has made roughly 80 investments totaling about $140 million since inception. While it has invested in some healthcare and biomed portfolio companies, Club 100 Plus itself is an investor, not a life sciences operating company with an internal therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Club100Plus Investments Group.